It's quick, it's long-lasting, and it's a winner.
Cellfina™, a minimally invasive procedure that reduces the appearance of cellulite on women's thighs and butts, had a great 2015. It received an FDA approval earlier in the year, then took a Best of Beauty Breakthrough win for the 2015 Allure Best of Beauty Awards.
The Bengtson Center for plastic surgery in Grand Rapids has offered the headline-grabbing Cellfina™ since late July of 2015, recognizing the widespread problem of cellulite that virtually all women around Grand Rapids, Michigan, and the rest of the United States face at some point in their lives.
Dr. Brad Bengtson and his team chose to begin offering the treatment because of its ease of use, its immediate effectiveness, and its results that last at least two years. The “at least” is because that's the time that's passed since the clinical trial that led to the FDA approval. Every day that goes by with the initial results looking as good as they did just after the treatment only adds to the procedure's already sizable appeal.
The Allure honor was announced in September 2015, helping to close out the year with a positive outlook, both for the makers of Cellfina™ and for any woman seeking a solution to cellulite.
Patients who will enjoy the best Cellfina™ results have dimples—as opposed to longer, more stretched-out lines—on their lower half. Remember: Though cellulite is caused by connective bands that run through fat beneath the skin, it is not a “fat” issue. It can show up on women of all weights, sizes, and body types.
Talk to Dr. Brad Bengtson, Dr. Ryan Mitchell, and their team at the Bengtson Center about cellulite removal in Grand Rapids. For more information, schedule a consultation or call (616) 588-8880 or 1-877-822-8880.Written by Bengtson Center for Aesthetics & Plastic Surgery
2155 E Paris Ave SE
Suite 100, Grand Rapids, Michigan 49546
Plastic Surgeons Dr. Bengtson and Dr. Alfonso, along with the team at the Bengtson Center for Aesthetics & Plastic Surgery, provide advanced surgical and cosmetic treatments for patients from Grand Rapids, Birmingham, Detroit, and Kalamazoo, Michigan.Fees & Financing